ABLYNX DEMONSTRATES BIOEQUIVALENCE BETWEEN LIQUID AND LYOPHILISED FORMULATIONS OF ITS ANTI-vWF NANOBODY, CAPLACIZUMAB

Print E-mail
GlobeNewswire
Tuesday, 25 November 2014 19:06

Caplacizumab has first-in-class potential for the treatment of thrombotic thrombocytopenic purpura (TTP)

On track to start Phase III study in patients with acquired TTP in mid-2015

GHENT, Belgium, Nov. 26, 2014 (GLOBE NEWSWIRE)

Read more...
 

Roka Bioscience to Present at the Piper Jaffray Healthcare Conference

Print E-mail
PRNewsWire
Tuesday, 25 November 2014 17:29
WARREN, N.J., Nov. 25, 2014/PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ:ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the
Read more...
 

La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa

Print E-mail
PRNewsWire
Tuesday, 25 November 2014 17:06
Read more...
 

Fundraiser Provides Social Outlet for Children and Youth With Disabilities

Print E-mail
MarketWired
Tuesday, 25 November 2014 16:12
Read more...
 

Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division

Print E-mail
PRNewsWire
Tuesday, 25 November 2014 15:15
MINNEAPOLIS, Nov. 25, 2014/PRNewswire/ -- Bio‑Techne Corporation (NASDAQ:TECH) announced today that it has appointed Robert Gavinto serve in a newly
Read more...
 

Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants

Print E-mail
PRNewsWire
Tuesday, 25 November 2014 15:15
Read more...
 

Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference

Print E-mail
PRNewsWire
Tuesday, 25 November 2014 15:15
Halozyme Therapeutics, Inc. Logo.
Read more...
 

La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe

Print E-mail
PRNewsWire
Tuesday, 25 November 2014 15:09
Read more...
 

Vical to Present at the Piper Jaffray 26th Annual Healthcare Conference

Print E-mail
GlobeNewswire
Tuesday, 25 November 2014 15:00

SAN DIEGO, Nov. 25, 2014 (GLOBE NEWSWIRE)

Read more...
 

Medal of Honor Recipient and Retired U.S. Army Ranger Leroy Petry Joins Honorary Advisory Board for Boulder Crest Retreat

Print E-mail
MarketWired
Tuesday, 25 November 2014 14:48

SOURCE: Boulder Crest for Military & Veteran Wellness

Medal of Honor Recipient and War Veteran Continues His Support of Veterans as a Board Member for

Read more...
 

Will Telemedicine Transform Healthcare in 2015?

Print E-mail
MarketWired
Tuesday, 25 November 2014 14:14

SOURCE: CloudVisit Telemedicine

COLD SPRING, NY--(Marketwired - Nov 25, 2014) -  Healthcare professionals are looking toward 2015 with predictions for the future of healthcare. With

Read more...
 

KLAS Report Rates TransUnion Healthcare's Patient Payment Estimation and Propensity to Pay Solutions the Highest of Any Vendor

Print E-mail
MarketWired
Tuesday, 25 November 2014 13:46

CHICAGO, IL--(Marketwired - Nov 25, 2014) -  TransUnion Healthcare announced today it has been rated the highest performing vendor by the KLAS 2014 Patient

Read more...
 

Quotient Limited Announces $27 Million Private Placement

Print E-mail
GlobeNewswire
Tuesday, 25 November 2014 13:43

JERSEY, Channel Islands--Quotient Limited ("Quotient") (Nasdaq:QTNT), a commercial-stage diagnostics company, today announced that it has entered into agreements to issue to certain subscribers 2,000,000 ordinary shares at $9.50 per share and 850,000 pre-funded warrants at $9.49 per warrant, exercisable for up to 850,000 ordinary shares at $0.01 per ordinary share.

Read more...
 

BlueOcean Signs an Exclusive Long Term Processing Agreement

Print E-mail
MarketWired
Tuesday, 25 November 2014 13:30

TORONTO, ONTARIO--(Marketwired - Nov. 25, 2014) -BlueOcean NutraSciences Inc. ("BlueOcean") (TSX VENTURE:BOC) announces the signing of an Exclusive Long Term Processing Agreement ("Agreement") with

Read more...
 

Vela Diagnostics Announces the Listing of Their Next-Generation Sequencing System With the U.S. FDA as a Class II Medical Device

Print E-mail
MarketWired
Tuesday, 25 November 2014 13:00
Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 2219

Newsletter

BioMedReports This is how a living, beating heart is grown from stem cells. http://t.co/MLrFZyj3la
5hreplyretweetfavorite
BioMedReports FDA Orders New Label For Biogen Idec's MS Drug; Exact Sciences Announces Final Payment Decision for Cologuard®... http://t.co/LwIBwixMkt
5hreplyretweetfavorite
BioMedReports OncoMed Offers Data from Demcizumab; Celgene Receives Positive CHMP Opinion For OTEZLA: Below is a look at som... http://t.co/ZkvEC7x99Y
Benzinga.com supporter Seeking Alpha Certified